You are here

Article info

Article menu
Download PDFPDF
Letters
Tofacitinib, a JAK inhibitor, inhibits human B cell activation in vitro

Authors

  1. Correspondence to Professor Yoshiya Tanaka, The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu, Fukuoka 807-8555, Japan; tanaka{at}med.uoeh-u.ac.jp
View Full Text

Citation

Wang S, Iwata S, Nakayamada S, et al
Tofacitinib, a JAK inhibitor, inhibits human B cell activation in vitro
Annals of the Rheumatic Diseases 2014;73:2213-2215.

Publication history

  • Received March 23, 2014
  • Revised August 8, 2014
  • Accepted August 10, 2014
  • First published August 25, 2014.
Online issue publication 
April 13, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions